Acute coronary syndromes
KEYWORDS: people, coronary, acute, pci, risk, acute coronary, therapy, recommendations, committee, evidence, angina, unstable, nstemi, unstable angina, offer

short explanation of why the committee made the 2020 recommendations and how they might affect practice, see the rationale and impact section on dual antiplatelet therapy for people with STEMI not treated with PCI. Full details of the evidence and the committee's discussion are in evidence review A: antiplatelet therapy. 1.1.26 Offer medical management to people with acute STEMI who are ineligible for any reperfusion therapy. [2013] Acute coronary syndromes (NG185) Tests before discharge 1.1.27 Assess left ventricular function in all people who have had a STEMI. [2013] 1.2 NSTEMI and unstable angina â€“ early management NICE has produced a visual summary of the recommendations on the early management of NSTEMI and unstable angina. Initial drug therapy 1.2.1 Offer aspirin as soon as possible to all people with unstable angina or non-ST-segment elevation myocardial infarction (NSTEMI) and continue indefinitely unless contraindicated by bleeding risk or aspirin hypersensitivity. [2010] 1.2.2 Offer people with unstable angina or NSTEMI a single loading dose of 300-mg aspirin as soon as possible unless there is clear evidence that they are allergic to it. [2010] 1.2.3 Offer fondaparinux to people with unstable angina or NSTEMI who do not have a high bleeding risk, unless they are
